Top Stories
The findings highlight the need to carefully integrate AI-based classification systems into healthcare.
The deal puts Cortechs.ai’s NeuroQuant MS inside Viz.ai’s hospital workflow, linking structured MRI analysis with the follow-up steps used to manage MS patients.
The startup’s AI prescription support platform will give the gastroenterology group a closer look at access delays affecting more than 60 million Americans living with digestive diseases.
The company's Alturion system has secured FDA 510(k) clearance and CE mark certification to help improve efficiency in busy care settings.
The sale price represents a roughly 35% discount to the $750 million ResMed paid to acquire MatrixCare from OMERS Private Equity in 2018.
Conference News
FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced th...
Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical developmentP...
Heartflow Plaque StagingTM, the only staging tool based on total plaque volume*, is now included with every Heartflow Plaque AnalysisData from over 36,000 patients validate the accuracy, reproducibili...
Analyses across Kisunla (donanemab-azbt) trials providing further insights into the benefit-risk profile from long-term extension dataNew data compares the diagnostic performance of P-tau217 blood tes...
BOSTON, July 8, 2026 /PRNewswire/ -- Linus Health, an AI-driven brain health company focused on early detection and proactive intervention, will share three poster presentations at the Alzheimer's Ass...
